Informação sobre produto
LCB-2853 is a synthetic drug that has been shown to inhibit the biosynthesis of prostaglandins. LCB-2853 was shown to be a potent inhibitor of two major cyclooxygenases, COX-1 and COX-2, in rat erythrocytes and human platelets. It also inhibited TXA2 receptor binding, which leads to suppression of platelet aggregation. LCB-2853 is not active against acetylsalicylic acid or other nonsteroidal antiinflammatory drugs (NSAIDs) and does not activate the TxA2 receptor. This drug has been shown to be effective in animals with muscle injury and can be used for the treatment of muscle pain.
LCB-2853 inhibits the production of prostanoids by blocking COX enzymes and inhibiting TXA2 receptor binding. This causes a decrease in inflammation and pain while also reducing blood clotting.
Propriedades químicas
Consulta técnica sobre: 3D-RFA33510 LCB-2853
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
